Paper39348473
Research Progress of γδT Cells in Tumor Immunotherapy.
Li Y and 3 others. Cancer Control, 2024. Cited by 7 papers, by iCite.
Cite this record
ConductScience Library. Research Progress of γδT Cells in Tumor Immunotherapy. Papers, record 39348473. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39348473
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Neoplasms | Major topic |
| Immunotherapy | Major topic |
| Humans | |
| Intraepithelial Lymphocytes | |
| Receptors, Antigen, T-Cell, gamma-delta |
Source PubMed
References77
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21647691 | Pilot trial of interleukin-2 and zoledronic acid to augment γδ T cells as treatment for patients with refractory renal cell carcinoma. | Cancer Immunol Immunother | 2011 | https://conductscience.org/library/papers/21647691 | PubMed |
| 2 | 30736852 | Allogenic Vγ9Vδ2 T cell as new potential immunotherapy drug for solid tumor: a case study for cholangiocarcinoma. | J Immunother Cancer | 2019 | https://conductscience.org/library/papers/30736852 | PubMed |
| 3 | 33013819 | Immune Effects of γδ T Cells in Colorectal Cancer: A Review. | Front Immunol | 2020 | https://conductscience.org/library/papers/33013819 | PubMed |
| 4 | 15287953 | Human gammadelta T cells as mediators of chimaeric-receptor redirected anti-tumour immunity. | Br J Haematol | 2004 | https://conductscience.org/library/papers/15287953 | PubMed |
| 5 | 31919129 | Butyrophilin 2A1 is essential for phosphoantigen reactivity by γδ T cells. | Science | 2020 | https://conductscience.org/library/papers/31919129 | PubMed |
| 6 | 30050536 | New Insights Into the Regulation of γδ T Cells by BTN3A and Other BTN/BTNL in Tumor Immunity. | Front Immunol | 2018 | https://conductscience.org/library/papers/30050536 | PubMed |
| 7 | 38236249 | Ziv-aflibercept plus pembrolizumab in patients with advanced melanoma resistant to anti-PD-1 treatment. | Cancer Immunol Immunother | 2024 | https://conductscience.org/library/papers/38236249 | PubMed |
| 8 | 37063836 | A close look at current γδ T-cell immunotherapy. | Front Immunol | 2023 | https://conductscience.org/library/papers/37063836 | PubMed |
| 9 | 29740448 | Working in "NK Mode": Natural Killer Group 2 Member D and Natural Cytotoxicity Receptors in Stress-Surveillance by γδ T Cells. | Front Immunol | 2018 | https://conductscience.org/library/papers/29740448 | PubMed |
| 10 | 16850345 | Safety profile and anti-tumor effects of adoptive immunotherapy using gamma-delta T cells against advanced renal cell carcinoma: a pilot study. | Cancer Immunol Immunother | 2007 | https://conductscience.org/library/papers/16850345 | PubMed |
| 11 | 18301889 | Phase-I study of Innacell gammadelta, an autologous cell-therapy product highly enriched in gamma9delta2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma. | Cancer Immunol Immunother | 2008 | https://conductscience.org/library/papers/18301889 | PubMed |
| 12 | 35295709 | Folate Receptor-Alpha Targeted 7x19 CAR-γδT Suppressed Triple-Negative Breast Cancer Xenograft Model in Mice. | J Oncol | 2022 | https://conductscience.org/library/papers/35295709 | PubMed |
| 13 | 24528541 | Successful adoptive transfer and in vivo expansion of haploidentical γδ T cells. | J Transl Med | 2014 | https://conductscience.org/library/papers/24528541 | PubMed |
| 14 | 22306909 | Tumor-promoting versus tumor-antagonizing roles of γδ T cells in cancer immunotherapy: results from a prospective phase I/II trial. | J Immunother | 2012 | https://conductscience.org/library/papers/22306909 | PubMed |
| 15 | 35784326 | Gamma Delta T-Cell Based Cancer Immunotherapy: Past-Present-Future. | Front Immunol | 2022 | https://conductscience.org/library/papers/35784326 | PubMed |
| 16 | 29296543 | IL-21 promotes the development of a CD73-positive Vγ9Vδ2 T cell regulatory population. | Oncoimmunology | 2017 | https://conductscience.org/library/papers/29296543 | PubMed |
| 17 | 32714329 | Gamma-Delta CAR-T Cells Show CAR-Directed and Independent Activity Against Leukemia. | Front Immunol | 2020 | https://conductscience.org/library/papers/32714329 | PubMed |
| 18 | 27667711 | Regulation of NKG2D Expression and Signaling by Endocytosis. | Trends Immunol | 2016 | https://conductscience.org/library/papers/27667711 | PubMed |
| 19 | 29163482 | Current Advances in γδ T Cell-Based Tumor Immunotherapy. | Front Immunol | 2017 | https://conductscience.org/library/papers/29163482 | PubMed |
| 20 | 32939032 | Allogeneic Vγ9Vδ2 T-cell immunotherapy exhibits promising clinical safety and prolongs the survival of patients with late-stage lung or liver cancer. | Cell Mol Immunol | 2021 | https://conductscience.org/library/papers/32939032 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42220528 | Editorial: Role of gamma delta T cells in cancer immunotherapy. | Front Immunol | 2026 | https://conductscience.org/library/papers/42220528 | PubMed |
| 40136407 | Potential Benefits of Adding Alendronate, Celecoxib, Itraconazole, Ramelteon, and Simvastatin to Endometrial Cancer Treatment: The EC5 Regimen. | Curr Issues Mol Biol | 2025 | https://conductscience.org/library/papers/40136407 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| HLA-C | 3107 | PubTator's text mining | https://conductscience.org/library/genes/3107 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39348473
GET https://conductscience.org/api/papers/v1/39348473/references?page=2